AstraZeneca Pharmaceuticals LP
New data presented at ATS 2024 show the potential of TEZSPIRE to play a[...]
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP[...]
05/02/2024 | Press release | Distributed by Public on 05/02/2024 10:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-MFP MONTHLY SCHEDULE OF PORTFOLIO HOLDINGS OF MONEY MARKET FUNDS |
Please select the service you want to use:
Smartlinks | Penn Series Funds Inc. | News | Health | Finance | Company News | Investment Funds | Private Companies | Investment Companies
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact